Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Splicing factor gene mutations are the most frequent mutations found in patients with the myeloid malignancy myelodysplastic syndrome (MDS), suggesting that spliceosomal dysfunction plays a major role in disease pathogenesis. The aberrantly spliced target genes and deregulated cellular pathways asso...
Հիմնական հեղինակներ: | Pellagatti, A, Boultwood, J |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2016
|
Նմանատիպ նյութեր
-
Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
: Armstrong, R, և այլն
Հրապարակվել է: (2017) -
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
: Boultwood, J, և այլն
Հրապարակվել է: (2014) -
Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
: Pellagatti, A, և այլն
Հրապարակվել է: (2017) -
Gene expression profiling in the myelodysplastic syndromes.
: Pellagatti, A, և այլն
Հրապարակվել է: (2005) -
Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
: Johanna Flach, և այլն
Հրապարակվել է: (2020-09-01)